Heartflow Stock
HeartFlow is a medical technology company that had developed FFRct Analysis, the first non-invasive solution that enables physicians to more accurately evaluate whether a patient has significant coronary artery disease (CAD) based on both anatomy and physiology.
Sign up for SecondMarket™ to view the market and buy or sell Heartflow Stock
Buy + SellSee Heartflow Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Heartflow Stock Valuation + Share Prices
View real-time Tape D™ data on Heartflow stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get StartedHeartflow Management Team
Director
Julie Cullivan
Director
Lonnie Smith
Director
Jeff Lightcap
Co-founder, CEO, Director
John Stevens
Founder, Director, CTO
Charles A. Taylor
Chief Regulatory & Quality Officer
Windi Hary
CISO
Austin Davis
Director
William C. Weldon
Director
Casey Tansey
President, COO, Director
John Farquhar
Heartflow Major Investors
Hayfin Capital Management LLP
U.S. Venture Partners
Bain Capital, LP
Bain Capital, LP
Janus Henderson
Baillie Gifford & Co
Sandbox Industries LLC
Martis Capital
HealthCor Partners Management, L.P.
HealthCor Partners Management, L.P.
Wellington Management Company LLP
Capricorn Investment Group LLC